Experimental Hematology Group - VHIO

VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.

Nirmatrelvir/ritonavir in COVID-19 patients with haematological

Experimental Hematology & Oncology

Conservation of copy number profiles during engraftment and

VHIO 'on the ground' at ASH 2021: seeking out more effective

Sarcoma Translational Research Group - VHIO

Carlota Pagès Geli - PHD Candidate - Vall d´Hebron Institute of

Molecular Oncology Group - VHIO

The FANCM:p.Arg658* truncating variant is associated with risk of

Ref. 23-2023 Staff Researcher (NGS) (Process Closed) - VHIO

PDF) Recent Advances in the Targeting of Epigenetic Regulators in